BIOSENIC SA (BIOS.BR) Stock Price, Forecast & Analysis
Europe • Euronext Brussels • EBR:BIOS • BE0974280126
BIOS.BR Key Statistics, Chart & Performance
The current stock price of BIOS.BR is 0.002 EUR. In the past month the price increased by 19.05%. In the past year, price decreased by -21.87%.
BIOS.BR Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BIOS.BR. When comparing the yearly performance of all stocks, BIOS.BR is a bad performer in the overall market: 81.6% of all stocks are doing better.
BIOS.BR Financial Highlights
Over the last trailing twelve months BIOS.BR reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 92.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.55% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BIOS.BR Forecast & Estimates
BIOS.BR Ownership
BIOS.BR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 28.23 | 44.408B | ||
| 1AE | ARGENX SE | 28.28 | 44.383B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.29B | ||
| 2X1 | ABIVAX SA | N/A | 7.491B | ||
| ABVX | ABIVAX SA | N/A | 7.46B | ||
| GXE | GALAPAGOS NV | N/A | 1.918B | ||
| GLPG | GALAPAGOS NV | N/A | 1.915B | ||
| 6IV | INVENTIVA SA | N/A | 1.015B | ||
| IVA | INVENTIVA SA | N/A | 973.063M | ||
| NANO | NANOBIOTIX | N/A | 880.66M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About BIOS.BR
Company Profile
BioSenic SA is a biotech company engaged in the development of clinical assets . The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 3 full-time employees. The company went IPO on 2015-02-06. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. The company also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).
Company Info
BIOSENIC SA
Rue Granbonpre 11, Batiment H (bte 24)
Mont-Saint-Guibert BRABANT-WALLON BE
Employees: 3
Phone: 32493097366
BIOSENIC SA / BIOS.BR FAQ
What does BIOSENIC SA do?
BioSenic SA is a biotech company engaged in the development of clinical assets . The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 3 full-time employees. The company went IPO on 2015-02-06. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. The company also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).
What is the stock price of BIOSENIC SA today?
The current stock price of BIOS.BR is 0.002 EUR. The price decreased by -20% in the last trading session.
What is the dividend status of BIOSENIC SA?
BIOS.BR does not pay a dividend.
What is the ChartMill technical and fundamental rating of BIOS stock?
BIOS.BR has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Who owns BIOSENIC SA?
You can find the ownership structure of BIOSENIC SA (BIOS.BR) on the Ownership tab.